Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 511,930 shares at $153.91 ($80.7M) on 2021-04-19, disclosed to the SEC on 2021-04-19.
Open-market sale of $80.7M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.67 | 6,242 | $978K | 1.2% |
| 2 | $156.67 | 6,242 | $978K | 1.2% |
| 3 | $157.12 | 13,465 | $2.1M | 2.6% |
| 4 | $157.12 | 13,465 | $2.1M | 2.6% |
| 5 | $158.38 | 43,845 | $6.9M | 8.6% |
| 6 | $158.38 | 43,845 |
| $6.9M |
| 8.6% |
| 7 | $159.08 | 64,664 | $10.3M | 12.8% |
| 8 | $159.08 | 64,664 | $10.3M | 12.8% |
| 9 | $160.31 | 27,191 | $4.4M | 5.4% |
| 10 | $160.31 | 27,191 | $4.4M | 5.4% |
| 11 | $161.12 | 1,700 | $274K | 0.3% |
| 12 | $157.09 | 6,774 | $1.1M | 1.3% |
| 13 | $157.09 | 6,774 | $1.1M | 1.3% |
| 14 | $158.01 | 11,156 | $1.8M | 2.2% |
| 15 | $158.01 | 11,156 | $1.8M | 2.2% |
| 16 | $158.70 | 33,093 | $5.3M | 6.5% |
| 17 | $158.70 | 33,093 | $5.3M | 6.5% |
| 18 | $159.61 | 100 | $16K | 0.0% |
| 19 | $151.17 | 10,122 | $1.5M | 1.9% |
| 20 | $151.17 | 10,122 | $1.5M | 1.9% |
| 21 | $152.01 | 8,555 | $1.3M | 1.6% |
| 22 | $152.01 | 8,555 | $1.3M | 1.6% |
| 23 | $153.03 | 22,280 | $3.4M | 4.2% |
| 24 | $153.03 | 22,280 | $3.4M | 4.2% |
| 25 | $153.91 | 1,813 | $279K | 0.3% |
| 26 | $153.91 | 1,813 | $279K | 0.3% |
| 27 | $155.29 | 2,901 | $450K | 0.6% |
| 28 | $155.29 | 2,901 | $450K | 0.6% |
| 29 | $156.00 | 4,594 | $717K | 0.9% |
| 30 | $156.80 | 667 | $105K | 0.1% |
| 31 | $156.80 | 667 | $105K | 0.1% |
| Total | $157.60 avg | 511,930 | $80.7M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |